Stockhead on MSN21h
Long Shortz with Island Pharmaceuticals: Phase 2b trial into dengue fever kicks off
Island Pharmaceuticals joins Fraser Palamara on Stockhead TV to talk about its Phase 2b trial of ISLA-101 in dengue fever. ... Read More The post Long Shortz with Island Pharmaceuticals: Phase 2b ...
Hosted on MSN2d
Island Pharmaceuticals starts phase 2b dengue trial
Island Pharmaceuticals has commenced its phase 2b clinical trial of lead drug ISLA-101 – for potentially treating dengue ...
Business Insider24d
Island Pharmaceuticals Issues 6 Million New Securities
Island Pharmaceuticals Ltd (AU:ILA) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...
Nasdaq21d
Island Pharmaceuticals Announces Upcoming Shareholder Meeting
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Island Pharmaceuticals Ltd is set to hold an Extraordinary General Meeting on January 28, 2025, encouraging ...
Stockhead on MSN2d
Health Check: Which stock just dumped 19% on earnings downgrade?
Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...
Regeneron Science Talent Search scholars: Long Island has 49 semifinalists, more than any other U.S. region
Long Island schools have produced dozens of scholars year after year. The region had 50 semifinalists last year and three of ...
Yahoo Finance11d
2024 Rising Stars Shine at iC³ Summit: Celebrating Progress and Setting the Stage for 2025
Island Pharmaceuticals pioneers antiviral drug development to combat infectious diseases worldwide. Opsin Biotherapeutics innovates in vision restoration therapies, transforming treatment ...